J.L. Morison to expand pharmaceutical manufacturing
View(s):Hemas Holdings, new owners of J.L. Morison Son & Jones (Ceylon) (JLM), is looking at expanding its generic pharmaceutical manufacturing operation at JLM, officials said.
“This is still at a planning stage and we will know the cost structure by early next year,” JLM CEO Trehan Perera told the Business Times. He added that the government’s plan to initiate ‘Guaranteed Buy Back’ agreements in a Public-Private Partnership scheme that would see quality medicines at affordable prices for the public has necessitated their expansion plans. “In turn this will give the local manufacturers in the pharmaceutical industry more depth and recognition,” he said. The JLM Group has a portfolio of well-established consumer brands including Lacto Calamine, Valmelix, Morrison’s Gripe Mixture and Morrison’s Baby products. “These are strong brands and the brands that we own are slightly different.” As an example, Mr. Perera said that JLM’s Morison’s Baby and Hemas’ Baby Cheramy are slightly different propositions and they have independent brand equity.
comments powered by Disqus